Gene · 1241
Papers1,557
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,557
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Discovery of Chromone Derivatives as Selective BLT1 Inhibitors for Alleviating Acute Lung Injury and Sepsis. | J Med Chem | 2026 | 41696851 | PubTator, text mining | PubMed |
| LTB4 Activates the MAP Kinase Pathway in Endothelial Cells to Cause Long-Lasting Neutrophil Tethering, MCP-1 and NO Releases. | Scand J Immunol | 2026 | 41482602 | PubTator, text mining | PubMed |
| Plasma immune proteome-based risk score predicts survival in advanced gastric cancer treated with PD-1 inhibitors and chemotherapy. | Front Immunol | 2025 | 41601673 | PubTator, text mining | PubMed |
| CD Molecules Nomenclature 2025: Antibody Validation and Expression Profiling of Immune System G Protein-Coupled Receptors. | Eur J Immunol | 2025 | 41420480 | PubTator, text mining | PubMed |
| Structure-based identification of compounds with potential as selective BLT1 antagonists. | Sci Rep | 2025 | 41381763 | PubTator, text mining | PubMed |
| Rapid autofluorescence flow cytometric analysis of agonist-induced neutrophil and eosinophil polarization reveals novel insights into 5-oxo-ETE-mediated granulocyte activation. | J Inflamm (Lond) | 2025 | 41199211 | PubTator, text mining | PubMed |
| Identification of genetically-supported new drug targets for osteomyelitis based on druggable genomes. | Hum Genomics | 2025 | 41057938 | PubTator, text mining | PubMed |
| Arachidonic acid metabolism in metabolic dysfunction-associated steatotic liver disease and liver fibrosis. | Hepatol Commun | 2025 | 40879475 | PubTator, text mining | PubMed |
| Temporal phenotyping of neutrophils in post-cardiac arrest syndrome and extracorporeal membrane oxygenation-assisted resuscitation: A pilot study. | PLoS One | 2025 | 40743049 | PubTator, text mining | PubMed |
| Competing chemical gradients change chemotactic dynamics and cell distribution. | ArXiv | 2025 | 40740525 | PubTator, text mining | PubMed |
| Microarray Analysis Reveals Sepsis Is a Syndrome with Hyperactivity of TH17 Immunity, with Over-Presentation of the Treg Cell Cytokine TGF-β. | Curr Issues Mol Biol | 2025 | 40699834 | PubTator, text mining | PubMed |
| Unraveling the Role of Leukotriene A4 Hydrolase in Hepatocellular Carcinoma: Implications for Targeted Therapy and Tumor Progression. | Dig Dis Sci | 2025 | 40580380 | PubTator, text mining | PubMed |
| LTB4 is converted into a potent human neutrophil NADPH oxidase activator via a receptor transactivation mechanism in which the BLT1 receptor activates the free fatty acid receptor 2. | Prostaglandins Leukot Essent Fatty Acids | 2025 | 40199055 | PubTator, text mining | PubMed |
| The LTB4-BLT1 axis attenuates influenza-induced lung inflammation by suppressing NLRP3 activation. | Cell Death Discov | 2025 | 40189592 | PubTator, text mining | PubMed |
| Epigenetic Perspectives and Their Prognostic Value in Early Recurrence After Hepatocellular Carcinoma Resection. | Cancers (Basel) | 2025 | 40075616 | PubTator, text mining | PubMed |
| CML With Mutant ASXL1 Showed Decreased Sensitivity to TKI Treatment via Upregulation of the ALOX5-BLTR Signaling Pathway. | Cancer Sci | 2025 | 39905783 | PubTator, text mining | PubMed |
| Exploring gene expression, alternative splicing events and RNA-binding proteins changes in PBMC from patients with hyperuricemia. | Gene | 2025 | 39828062 | PubTator, text mining | PubMed |
| Alpha-Lipoic Acid-Mediated Inhibition of LTB4 Synthesis Suppresses Epithelial-Mesenchymal Transition, Modulating Functional and Tumorigenic Capacities in Non-Small Cell Lung Cancer A549 Cells. | Curr Ther Res Clin Exp | 2025 | 39816494 | PubTator, text mining | PubMed |
| Structure Diversity and Properties of Some Bola-like Natural Products. | Mar Drugs | 2024 | 39852505 | PubTator, text mining | PubMed |
| Potential shared mechanisms in atopic dermatitis and type 2 diabetes identified via transcriptomic and machine learning approaches. | Sci Rep | 2024 | 39681684 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1241/papers?page=2